Guardian Pharmacy Services, Inc. (NYSE:GRDN) Shares Purchased by New York State Common Retirement Fund

New York State Common Retirement Fund boosted its position in Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 16.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 323,257 shares of the company’s stock after purchasing an additional 44,709 shares during the quarter. New York State Common Retirement Fund owned about 0.51% of Guardian Pharmacy Services worth $6,872,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Nuveen Asset Management LLC grew its holdings in Guardian Pharmacy Services by 2.9% in the 4th quarter. Nuveen Asset Management LLC now owns 547,140 shares of the company’s stock valued at $11,085,000 after buying an additional 15,550 shares during the period. GAMMA Investing LLC purchased a new stake in shares of Guardian Pharmacy Services during the 1st quarter worth about $170,000. Charles Schwab Investment Management Inc. purchased a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth about $544,000. Northern Trust Corp purchased a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth about $1,479,000. Finally, Wells Fargo & Company MN grew its holdings in shares of Guardian Pharmacy Services by 353.7% during the 4th quarter. Wells Fargo & Company MN now owns 6,715 shares of the company’s stock worth $136,000 after purchasing an additional 5,235 shares during the period.

Insider Buying and Selling

In other news, insider Fred Burke sold 747,102 shares of the company’s stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $20.16, for a total value of $15,061,576.32. Following the completion of the sale, the insider owned 551,724 shares in the company, valued at $11,122,755.84. This represents a 57.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider David K. Morris sold 369,212 shares of the company’s stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $20.16, for a total value of $7,443,313.92. Following the completion of the sale, the insider owned 283,042 shares of the company’s stock, valued at approximately $5,706,126.72. This trade represents a 56.61% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 11,344,912 shares of company stock valued at $228,713,426. Company insiders own 63.71% of the company’s stock.

Analyst Upgrades and Downgrades

GRDN has been the topic of several recent research reports. Raymond James Financial set a $28.00 price target on Guardian Pharmacy Services and gave the stock an “outperform” rating in a research report on Wednesday, May 14th. Truist Financial reissued a “buy” rating and set a $28.00 price target (up from $25.00) on shares of Guardian Pharmacy Services in a research report on Monday, May 19th. Finally, Wall Street Zen lowered Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th.

Guardian Pharmacy Services Stock Performance

Shares of GRDN opened at $20.27 on Monday. The stock has a fifty day moving average price of $21.48 and a 200 day moving average price of $21.45. Guardian Pharmacy Services, Inc. has a 12 month low of $14.16 and a 12 month high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). The company had revenue of $329.31 million during the quarter, compared to analysts’ expectations of $321.21 million. On average, equities analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.